CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-09 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −2,734 | $153.47 | $420K | 46,724 |
| 2024-04-09 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −7,924 | $154.21 | $1.2M | 38,800 |
| 2024-03-13 | OYLER JOHN Chief Executive Officer | Sale | −2,737 | $176.35 | $483K | 9,595 |
| 2024-03-13 | OYLER JOHN Chief Executive Officer | Sale | −5,994 | $177.11 | $1.1M | 3,601 |
| 2024-03-13 | OYLER JOHN Chief Executive Officer | Sale | −1,801 | $178.10 | $321K | 1,800 |
| 2024-03-13 | OYLER JOHN Chief Executive Officer | Sale | −993 | $179.33 | $178K | 807 |
| 2024-03-13 | OYLER JOHN Chief Executive Officer | Sale | −307 | $180.26 | $55K | 500 |
| 2024-03-13 | OYLER JOHN Chief Executive Officer | Sale | −200 | $181.37 | $36K | 300 |
| 2024-03-13 | OYLER JOHN Chief Executive Officer | Sale | −200 | $182.63 | $37K | 100 |
| 2024-03-13 | OYLER JOHN Chief Executive Officer | Sale | −100 | $184.17 | $18K | 0 |
| 2024-03-12 | OYLER JOHN Chief Executive Officer | Sale | −6,598 | $162.74 | $1.1M | 43,402 |
| 2024-03-12 | OYLER JOHN Chief Executive Officer | Sale | −15,466 | $163.78 | $2.5M | 27,936 |
| 2024-03-12 | OYLER JOHN Chief Executive Officer | Sale | −12,069 | $164.49 | $2.0M | 15,867 |
| 2024-03-12 | OYLER JOHN Chief Executive Officer | Sale | −2,602 | $165.49 | $431K | 13,265 |
| 2024-03-12 | OYLER JOHN Chief Executive Officer | Sale | −733 | $166.44 | $122K | 12,532 |
| 2024-03-12 | OYLER JOHN Chief Executive Officer | Sale | −200 | $169.05 | $34K | 12,332 |
| 2024-03-11 | Glazer Donald W. Director | Gift | −82,020 | 2,702,123 | ||
| 2024-02-29 | BRANDICOURT OLIVIER Director | Grant or award · Share Option (Right to Buy) | +27,794 | 27,794 | ||
| 2024-02-29 | Wang Julia Aijun Chief Financial Officer | Sale | −397 | $167.08 | $66K | 0 |
| 2023-11-30 | Wang Xiaodong Director | Gift | −71,890 | 5,459,438 |
Page 41 of 71 · 1,406 trades